Not applicableStudy completedNCT04276272What this trial is testingD4 Choline Breast PET/CTWho this might be right forHER2-negative Breast CancerER Positive Breast CancerMetastatic Breast Cancer Imperial College London 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110What this trial is testingTesting Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 38
Early research (Phase 1)Looking for participantsNCT06253871What this trial is testingA Phase 1/1b Study of IAM1363 in HER2 CancersWho this might be right forHER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more Iambic Therapeutics, Inc 243
Testing effectiveness (Phase 2)Study completedNCT03819010What this trial is testingNeoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 -Who this might be right forBreast Cancer MedSIR 66
Not applicableStudy completedNCT03123263What this trial is testingEchocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast CancerWho this might be right forBreast Cancer Texas Tech University Health Sciences Center, El Paso 60
Early research (Phase 1)Looking for participantsNCT07361562What this trial is testingA Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor, AdultERBB2 Altered Breast CancerERBB2 Gene Amplification+3 more Cogent Biosciences, Inc. 100
Not applicableEnded earlyNCT02963363What this trial is testingAdapted Physical Activity for Breast Cancer HER2 Positive PatientWho this might be right forHER2 Positive Breast Cancer Centre Jean Perrin 36
Not applicableNot Yet RecruitingNCT07264985What this trial is testingGut Microbiota and Diarrhea in Breast Cancer Patients Receiving PyrotinibWho this might be right forBreast CancerDrug-Related Side EffectsDiarrhea Hubei Cancer Hospital 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04565054What this trial is testingAdjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBCWho this might be right forBreast Cancer Female West German Study Group 1,260
Not applicableUnknownNCT04365790What this trial is testingInvestigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer AdenocarcinomaWho this might be right forBreast Cancer Hellenic Cooperative Oncology Group 500
Testing effectiveness (Phase 2)Study completedNCT01817452What this trial is testingA Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT ProtocolWho this might be right forBreast Cancer West German Study Group 220
Testing effectiveness (Phase 2)Ended earlyNCT00864175What this trial is testingOpen Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast CancerWho this might be right forBreast Cancer Incyte Corporation 68
Not applicableStudy completedNCT01934478What this trial is testingRadiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast CancerWho this might be right forHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast Qingdao Central Hospital 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03161353What this trial is testingChemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.Who this might be right forBreast Cancer MedSIR 377
Not applicableActive Not RecruitingNCT07342309What this trial is testingReal-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United StatesWho this might be right forMetastatic Breast Cancer Boehringer Ingelheim 7,933
Not applicableStudy completedNCT03437837What this trial is testingValidation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in ChinaWho this might be right forBreast CancerNeoadjuvant TherapyNeoplasm Staging+5 more Peking University First Hospital 1,077
Testing effectiveness (Phase 2)Study completedNCT01745965What this trial is testingA Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.Who this might be right forBreast Cancer West German Study Group 380
Testing effectiveness (Phase 2)Study completedNCT00773695What this trial is testingBevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 150
Testing effectiveness (Phase 2)Study completedNCT00524277What this trial is testingVaccine Therapy in Treating Patients With Breast CancerWho this might be right forBreast Cancer San Antonio Military Medical Center 456
Early research (Phase 1)Ended earlyNCT04504331What this trial is testingStudy of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast CancerWho this might be right forBreast CancerHER2-negative Breast CancerER Positive Breast Cancer+1 more Jennifer Lee Caswell-Jin 4